While biotechnology accounts for only 1 percent of the overall healthcare costs, the overall cost of biotechnology is growing faster than the economy along an unsustainable trajectory. Biotech drug sales are expected to top $60 billion by 2010. Still, the cost of biotechnology has to be compared with the cost of the disease in terms […]

Ariad Denied Declaratory Judgment Ariad Pharmaceuticals announced that the United States District Court for the District of Delaware denied their motion to dismiss the lawsuit filed by Amgen relating to their products Enbrel(R) and Kineret(R). In the lawsuit, Amgen is seeking a declaratory judgment that these products do not infringe U.S. Patent No. 6,410,516, covering […]

I will be attending the BIO Mid-America VentureForum on September 26-27 in Cleveland, OH. The VentureForum, co-hosted by Omeris, is the Midwest’s largest annual event for bioscience and medical device product and platform companies from across the country. Approximately 75 companies seeking seed, early-and late-stage funding will make presentations. If you will be attending the […]

The Boston Globe ran an article about Ohio Governor Bob Taft traveling to Boston looking to attract a few more companies — or at least their new or expanded facilities — for Ohio. On the heels of the recent acquisitions by Cincinnati’s Procter & Gamble Co. and Federated Department Stores of Boston’s Gillette Co. and […]

I don’t know what it is about wikis but there seems to be a wikification of the patent world. After the U.S. Patent and Trademark Office put out a draft Five Year Strategic Plan outlining their intention to develop a “peer review mechanism” that would enlist volunteers from the public to weigh in on applications, […]

Kevin Heller, the Tech Law Advisor and commissioner of the Legal Bloggers Fantasy Football League, is heading up Blawger Bowl III. The league is made up of draft teams managed by 12 law blawgers. Patent Baristas is participating – although how we got talked into this I’m not so sure. Current Roster: Anonymous Lawyer Bizz […]

If you’re familiar with the drug industry, it should come as no great shock that the Generic Pharmaceutical Association (GPhA) disagrees with a report put out by the Pharmaceutical Research and Manufacturers of America (PhRMA). According to a recent report commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA), wholesale price discounts off brand […]

As I was scrolling through i-Tunes looking for some summer music to download, I happened to come across the song “Buttons” at almost the same time the news reports had come on reporting that the Senate, in a 63-37 vote, gave final approval to expanding federal funding for embryonic stem-cell research, which many scientists believe […]